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Recently, high-throughput technologies have been made available which allow the measurement
of a broad spectrum of glycomics and lipidomics parameters in many samples. The aim of this
study was to apply these methods and investigate associations between 46 glycan and 183
lipid traits measured in blood of 2041 Europeans from three diﬀerent local populations
(Croatia - VIS cohort; Sweden - NSPHS cohort; Great Britain - ORCADES cohort). N-glycans
have been analyzed with High Performance Liquid Chromatography (HPLC) and lipids with
Electrospray Ionization Tandem Mass Spectrometry (ESI-MS/MS) covering sterol lipids,
glycerolipids, glycerophospholipids and sphingolipids in eight subclasses. Overall, 8418
associations were calculated using linear mixed eﬀect models adjusted for pedigree, sex, age and
multiple testing. We found 330 signiﬁcant correlations in VIS. Pearson’s correlation coeﬃcient
r ranged from 0.27 to 0.34 with corresponding p-values between 1.45  1019 and 4.83  106,
indicating statistical signiﬁcance. A total of 71 correlations in VIS could be replicated in NSPHS
(r = [0.19; 0.35], p = [4.16  1018; 9.38  105]) and 31 correlations in VIS were also found
in ORCADES (r = [0.20; 0.24], p = [2.69  1010; 7.55  105]). However, in total only 10
correlations between a subset of triantennary glycans and unsaturated phosphatidylcholine,
saturated ceramide, and sphingomyelin lipids in VIS (r = [0.18; 0.34], p = [2.98  1021; 1.69  1006])
could be replicated in both NSPHS and ORCADES. In summary, the results show strong and
consistent associations between certain glycans and lipids in all populations, but also population-speciﬁc
correlations which may be caused by environmental and genetic diﬀerences. These associations point
towards potential interactive metabolic pathways.
Introduction
The recent development of high-throughput methods has
enabled a new type of large-scale study which encompasses
thousands of samples and hundreds of traits, such as nucleic
acids, proteins, lipids and sugars.1 While the progress in the
ﬁelds of genomics and proteomics was rather fast, the develop-
ment of lipidomics and glycomics substantially lagged behind.
Reasons were the high diversity and complexity of lipids and
glycans and the resulting diﬃculties in their quantiﬁcation.
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However, recently high-throughput methods have also been
developed in the ﬁelds of lipidomics2 and glycomics3 which
now enable exciting new insights into these biological traits.
At present, software tools that could explain the observed
relations within complex data sets and model pathways and
their interactions from a systems biology perspective4,5 are still
under development.6,7 However, to get a better understanding
of the functional relevance, studies examining simple associa-
tions between a broad range of omics traits with selected traits
of medical importance have been conducted. For example,
genome-wide association studies correlate common variants
across the whole genome with traits of medical relevance,
e.g. classical blood lipids.8 These studies have contributed
enormously to the identiﬁcation of genes and to the under-
standing of their biological and medical relevance. However,
omics studies mostly concentrate on a single omics discipline
and selected traits of medical importance. Few studies
exist which try to understand the interactions between two
comprehensive sets of omics traits.9 Therefore, we conducted
the ﬁrst glycome- and lipidome-wide association study to
reveal interactions between these two major biological sub-
stance classes.
The glycome is deﬁned as the entire set of glycans of an
organism. Glycans are complex molecules which typically
contain between 10 and 15 monosaccharides that are linked
in a complicated manner. Glycosylation is the only post-
translational modiﬁcation that can produce substantial
structural changes to proteins by attaching between two and
ﬁve covalently bound glycans to proteins.10 It is not template
driven and the complexity of the glycoproteome is estimated to
be several orders of magnitude greater than for the proteome
itself.11 Glycans play an important role in many metabolic
processes, including protein folding, degradation and secretion,
cell signaling, immune function and transcription.12 Glycosyl-
ation is essential for multicellular life and its complete absence
is embryonically lethal.13 Dysregulation of glycosylation is
implicated in a wide range of diseases, including cancer,
diabetes, cardiovascular, congenital, immunological and infec-
tious disorders.14,15
The lipidome is the entire set of lipids of an organism.
Lipids can be classiﬁed in eight lipid categories of which not all
are observed in human cells.16,17 Lipids which are important
building blocks in the human cell membrane belong to sterol
lipids (e.g. cholesterol), glycerophospholipids (e.g. phosphatidyl-
choline/lecithin), and sphingolipids (e.g. sphingomyelin).
Sphingolipid- and cholesterol-rich lipid domains embedded
in glycerophospholipids play central roles in the assembly of
lipid rafts by forming an ordered and disordered liquid
phase.18,19 Lipid rafts are suggested to be involved in adipo-
cyte physiology, cardiovascular disease, and carcinogenesis.20
Glycerophospholipids are major components of biological
membranes and play a key role in cell survival. Phosphatidyl-
cholines (PCs), phosphatidylethanolamines (PEs), lyso-
phosphatidylcholines (LPCs) and PE-plasmalogens (PEPLs)
can be found in blood and the white matter of the central
nervous system.21,22 These glycerophospholipids play a crucial
role in cell survival and cellular protection against reactive
oxidant species (ROS) in peroxisomes through the PC,
phosphatidylserine (PS) and PE rheostat.23,24 Inﬂammation
is another pathway through which these glycerophospholipids
play a role in common disease, in particular related to obesity,
type 2 diabetes, and cardiovascular disease.9 A wide range of
disorders has been associated with altered circulating glycero-
phospholipids, in particular dyslipidemia, diabetes and coronary
heart disease.25–28 The sphingolipids comprise a complex
range of lipids in which fatty acids are linked via amide bonds
to a long-chain base or sphingoid. Sphingolipids also play
essential roles as structural components of cell membranes and
in cell signaling, and aﬀect health and disease.29,30
In the following, we present the ﬁrst comprehensive glycome-
and lipidome-wide association study between 46 N-glycan and
183 lipid traits in the human blood of 2041 individuals from
Croatia, Sweden, and Great Britain.
Experimental procedures
Study participants
We investigated three population-representative, pedigree-based,
cross-sectional data collections from local populations in
Croatia, Sweden, and Great Britain. All studies include a
comprehensive collection of data on family structure, lifestyle,
and blood samples for clinical chemistry, RNA and DNA
analyses, and medical history. The studies received approval
from the local ethics committees. All participants gave their
written informed consent.31 A brief description of each popula-
tion is given below:
The VIS study was conducted in the villages of Vis and
Komiza on the Dalmatian island of Vis, Croatia, between 2003
and 2004.32–36 We analyzed 720 participants for whom relevant
data was available, including 305 (42%) men and 415 (58%)
women, aged between 18 and 93 years. The blood samples
were collected under fasting conditions.
The NSPHS study (Northern Swedish Population Health
Study) was conducted in the community of Karesuando in the
subarctic region of the County of Norrbotten, Sweden, in
2006.37,38 We studied 601 participants for whom relevant data
was available including 281 (47%) men and 320 (53%) women,
aged between 18 and 91 years. The blood samples were taken
under non-fasting conditions to be able to model the eﬀect
of environmental covariates, e.g. dietary records, on blood
metabolites.
The ORCADES study (Orkney Complex Disease Study)
was conducted on the archipelago of Orkney, Scotland, Great
Britain.39,40 We examined 714 participants for whom relevant
data was available including 331 (46%) men and 383 (54%)
women, aged between 18 and 98 years.32–36 The blood samples
were collected under fasting conditions.
Analysis of N-glycans
Glycan release and labeling. The N-glycans from plasma
sample (5 ml) proteins were released and labelled with 2-amino-
benzamide (LudgerTag 2-AB labelling kit Ludger Ltd., Abingdon,
UK), as described previously.41 Labelled glycans were dried in
vacuum centrifuge and re-dissolved in a known volume of
water for further analysis.
Hydrophilic interaction high performance liquid chromato-
graphy (HILIC). Released glycans were subjected to hydrophilic
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interaction high performance liquid chromatography (HILIC)
on a 250  4.6 mm i.d. 5 mm particle packed TSKgel Amide
80 column (Tosoh Bioscience, Stuttgart, Germany) at 30 1C with
50 mM formic acid adjusted to pH 4.4 with ammonia solution as
solvent A and acetonitrile as solvent B. 60 min runs were
performed with ﬂuorescence detector set with excitation and
emission wavelengths of 330 and 420 nm, respectively. The
system was calibrated using an external standard of hydrolyzed
and 2-AB-labeled glucose oligomers from which the retention
times for the individual glycans were converted to glucose
units (GU).
The chromatograms obtained were all separated in the same
manner to 16 chromatographic areas and 13 for desialylated
glycans, regarding the peak resolutions and similarity of
glycan structures present as described before. The amounts
of glycans present in each area were expressed as a % of
the total integrated chromatogram (amount of total glycan
structures / total serum N-glycome).
Weak anion exchange (WAX)-HPLC. Glycans were separated
according to the number of sialic acids by weak anion
exchange HPLC. The analysis was performed using a Prozyme
GlycoSep C 75 mm  7.5 mm column (Prozyme, Leandro,
CA, USA) at 30 1C with 20% (v/v) acetonitrile in water as
solvent A and 0.1M acetic acid adjusted to pH 7.0 with ammonia
solution in 20% (v/v) acetonitrile as solvent B. Compounds were
retained on the column according to their charge density, the
higher charged compounds being retained the longest. A fetuin
N-glycan standard was used for calibration.
Sialidase digestion. Aliquots of the 2AB-labeled glycan pool
were dried down in 96-well PCR plates. To these, the following
was added: 1 ml of 500 mM sodium acetate incubation buﬀer
(pH 5.5), 1 ml (0.005 units) of ABS, Arthrobacter ureafaciens
sialidase (releases a2–3,6,8 sialic acid, Prozyme) and H2O to
make up to 10 ml. This was incubated overnight (16–18 h) at
37 1C and then passed through AcroPrept 96-ﬁlter plates, 350 mL
well, 10 K (Pall Corporation, PortWashington, NY,USA) before
being applied to the HPLC.
Glycan structural features. Levels of glycans sharing the
same structural features were approximated by adding the
structures having the same characteristic from either HILIC,
WAX or after sialidase treatment integrated glycan proﬁles.
Individual glycan structures present in each glycan group
are shown in Supplementary Table S1, ESI.w Glycans were
quantiﬁed from WAX proﬁles according the level of sialyl-
ation (monosialylated, disialylated, trisialylated, tetrasialylated).
Glycan features were deﬁned as: Core fucosylated glycans
(FUC–C) = DG6/(DG5+DG6)*100; Antennary fucosylated
glycans (FUC-A) = DG7/(DG5+DG7)*100; Biantennary
glycans (BA)=DG1+DG2+DG3+DG4+DG5+DG6+DG7;
Monosialylated biantennary glycans (BAMS) = (GP7+GP8)/
(DG5+DG6+DG7)*100; Disialylated biantennary glycans
BADS = (GP9+GP10+GP11)/(DG5+DG6+DG7)*100;
Triantennary glycans (TRIA) = DG8+DG9+DG10; Tetra-
antennary glycans (TA) =DG11+DG12+DG13; Nongalacto-
sylated glycans (G0) = DG1+DG2; Monogalactosylated
glycans (G1) = DG3+DG4; Digalactosylated glycans
(G2) = DG5+DG6+DG7; Trigalactosylated glycans
(G3) = GP12+GP13+GP14; Tetragalactosylated glycans
(G4) = GP15+GP16, Biantennary nongalactosylated glycan
(A2) = (GP1+DG1)/2 (Supplementary Table S2, ESIw).
Analysis of lipids
Total cholesterol (TC), low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C), and
triglycerides (TG) in the blood serum were quantiﬁed by
enzymatic photometric assays using an ADVIA1650 clinical
chemistry analyzer (Siemens Healthcare Diagnostics GmbH,
Eschborn, Germany).
EDTA plasma samples were quantiﬁed upon lipid extrac-
tion by direct ﬂow injection analysis.42 A precursor ion scan of
m/z 184 speciﬁc for phosphocholine containing lipids was
used for phosphatidylcholine (PC), sphingomyelin (SM) and
lysophosphatidylcholine (LPC).2
Glycerophospholipids and sphingolipids in the blood
plasma were quantiﬁed by electrospray ionization tandem
mass spectrometry (ESI-MS/MS) in positive ion mode as
described previously.42–45 A neutral loss scan of m/z 141
was used for phosphatidylethanolamine (PE)27 and PE-based
plasmalogens (PE-pls) which were analyzed according to
principles described elsewhere.46 Fragment ions of m/z 364,
380 and 382 were used for PE p16 : 0, p18 : 1 and p18 : 0
species, respectively. Ceramide (CER) was analyzed using a
fragment ion of m/z 264.45
Quantiﬁcation was achieved by calibration lines generated
by addition of naturally occurring lipid species to plasma and
internal standards belonging to the same lipid class (PC 14 : 0/
14 : 0, PC 22 : 0/22 : 0, PE 14 : 0/14 : 0, PE 20 : 0/20 : 0, LPC
13 : 0, LPC 19 : 0). Calibration lines were generated for the
following naturally occurring species: PC 34 : 1, 36 : 2, 38 : 4,
40 : 0 and PC O 16 : 0/20 : 4; LPC 16 : 0, 18 : 1, 18 : 0; PE 34 : 1,
36 : 2, 38 : 4, 40 : 6. Deisotopic and data analysis for all lipid classes
was performed by self-programmed Excel Macros according to
the principles described previously.42 Overall 183 lipids scores
including 151 lipid species from eight lipid subclasses were used in
the analysis (Supplementary Table S3, ESIw).
Statistical analysis
Association analysis. The studied cohorts are pedigree-based
samples from rural populations. This means that many partici-
pants are related to each other to varying degrees, but much
closer than a sample from an urban population. To obtain the
correct statistical inference, we used linear mixed eﬀects models
to adjust the blood parameters for relatedness, sex, and age.
We then used the residues to calculate Pearson r correlations
and perform conventional t-tests for correlations. We created
heatmap plots to visually present the correlational results.
Covariate selection. We adjusted the outcome for sex and
age, to ﬁnd generic interactive metabolic pathways independent
of sex or age. We did not include other covariates, such as diet,
BMI, smoking, or alcohol consumption, whose eﬀects on
some glycans or lipids have been demonstrated.47,48 First,
the inclusion of these covariates might remove important
variation in glycans or lipids which can give valuable information
on interactive pathways. Second, we wanted to use a generic
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statistical model with covariates which are more or less
relevant for all glycans or lipids.
Multiple testing. Overall we calculated associations between
46 glycan scores and 183 lipid scores in three diﬀerent popula-
tions which resulted overall in 25 254 statistical tests. A simple
Bonferroni-adjustment to control the global a error at a
0.05 level would have lead to a local a error threshold of
a = 0.05/(46*183*3) E 2  106. Therefore, we decided to
choose a more powerful closed test procedure with a discovery
and two replication steps to identify associations across
populations and to avoid false positive ﬁndings. We used the
VIS cohort as the discovery cohort because it was historically
the ﬁrst cohort for which all of the examined traits were
available and additionally is the cohort with the largest
amount of non-missing data. Since this cohort alone provided
a large number of consistent, signiﬁcant results, we did not use
the remaining data sets for discovery, but for replication.
Additionally, we adjusted the local type I error per analysis
step for the number of performed tests. In the discovery
analysis, we therefore adjusted for 46  183 tests, corresponding
to a local a error threshold of adiscovery E 5  106 since we
used only the Croatian cohort. In the replication analysis we
adjusted the local a error only for the number of signiﬁ-
cant associations in the discovery cohort, which we tried to
replicate, leading to areplication = 0.05/330 E 1  104. We
want to point out that these signiﬁcance criteria are rather
strict in our opinion for the following reasons: First, the
examined omics traits are highly correlated which substan-
tially reduces the number of independent tests. Second, the
populations are substantially diﬀerent regarding environ-
mental and genetic factors which means that it is much
more diﬃcult to replicate an association in another cohort.
Therefore, a failing replication can be caused either by
a false positive ﬁnding in the discovery phase and a false
negative ﬁnding in the replication phase, or by a true positive
result in the discovery phase and a true negative result in
the replication phase. In the last case, the discovery and
replication cohort show a really diﬀerent association pattern.
Finally, we report all conducted statistical tests to enable
the reader to evaluate the signiﬁcance of the ﬁndings as
recommended.49
Software. All analyses were performed with the statistical
analysis system R, Version 2.7.2.50
Results
We found 330 signiﬁcant glycan-lipid associations with
Pearson’s correlation coeﬃcient r ranging from 0.27 to
0.34 and corresponding p-values between 1.45 E19 and
4.83 E6 in the VIS cohort (Fig. 1). 175 signiﬁcant correla-
tions (r = [0.29–+0.41]; p = [3.02 E24; 4.87 E06]) were
observed in NSPHS (Fig. 2), and 165 signiﬁcant correlations
(r= [0.49; +0.49]; p= [6.40 E44; 4.71 E06]) were found
in ORCADES (Fig. 3).
Discovery in the Croatian Cohort (VIS)
Classical lipids. GP11, GP12, GP13, DG8, and DG10
glycan species showed mostly signiﬁcant positive associations
with TC, LDL-C, or TG except GP6 which correlated negatively
(r = [0.21; 0.32], p = [3.96 E18; 4.10 E06]). Regarding
glycan summary scores, BA, TRIA, Trisialo, and G3 were
mostly positively correlated with TC, LDL-C, and TG apart
from BA which associated negatively (r = [0.20; +0.23],
p= [3.78 E09; 8.67 E07]). HDL-C did not show signiﬁcant
relationships with glycans.
Glycerophospholipids. Signiﬁcant associations were observed
for 142 PC-glycan associations, 17 LPC-glycan associations,
83 PE-glycan associations, and 7 PEPL-glycan associations
(r = [0.27; +0.32]; p = [6.67 E18; 4.83 E06]). PCs
primarily associated with GP11, GP12, GP13, GP15, DG7,
DG8, DG11 as directly measured glycan species and derived
traits BA, TRIA, Disialo, Trisialo, and G3 (r= [0.27;+0.32];
p = [6.67 E18; 4.83 E06]). LPCs mainly correlated with
GP8, GP12, DG8, BAMS, Disialo (r = [0.18; +0.23];
p = [1.18 E09; 3.59 E06]). PEs were primarily linked
with GP4, GP12, GP13, DG10, BA, TRIA, Trisialo, G3
(r= [0.22; +0.26], p= [1.99 E11; 4.75 E06]). PEPLs were
only associated with DG10 (r = [0.18; 0.20], p = [1.97 E07;
4.20 E06]).
Sphingolipids. Signiﬁcant associations were observed for
24 SPM-glycan and 42 CER-glycan associations. SPMs
correlated mainly with DG8, DG10, BA, TRIA, and G3
(r = [0.20; +0.29], p = [1.09 E14; 4.76 E06]). CERs
associated primarily with GP11, GP13, GP14, DG8, DG10, BA,
TRIA, and G3 (r = [0.19–0.34], p = [1.45 E19; 4.2 E06]).
Replication in the Swedish Cohort (NSPHS)
Overall, 85 glycan-lipid associations discovered in VIS were
replicated in NSPHS (Table 1). Classical lipids such as TC,
LDL-C, and TG were correlated with GP12, DG8, DG10,
Trisialo, andG3 (r=[0.16;+0.40]; p=[3.78 E23; 9.11 E5]).
Of all glycerophospholipids, PCs showed 39 signiﬁcant correla-
tions, especially with GP12 and GP13 which are trigalactosyl-
ated glycans. Additionally, 3 LPCs were associated with GP8
and DG8 (r = [0.19–0.32]; p = [8.96 E15–9.38 E5]). Of
all sphingolipids, SPMs showed 13 signiﬁcant correlations
exclusively with DG10, and CERs with DG10 and GP11
(r = [0.22; 0.32]; p = [3.24 E15; 9.23 E8]).
Replication in the Scottish Cohort (ORCADES)
Overall, 31 glycan-lipid associations found in VIS were conﬁrmed
in ORCADES (Table 2). No correlations between classical
lipids and glycans were replicated. Of all glycerophospholipids,
PEs showed a total of 11, i.e., 9 with PCs and 3 with LPCs,
signiﬁcant associations with GP12, GP15, DG8, BAMS, or
TRIA (r = [0.20; +0.24], p = [2.79 E10; 7.55 E05]). Of
all sphingolipids, CERs showed 7, but SPMs only one signiﬁ-
cant association exclusively with DG10 (r = [0.15; 0.24],
p = [2.69 E10; 7.05 E5]). A schematic representation of
signiﬁcantly associated molecular structures of N-glycans and
lipids is provided in Fig. 4.
In total only 10 correlations between a subset of
triantennary glycans (DG8, DG10) and various unsaturated
phosphatidylcholine, saturated ceramide, and sphingomyelin
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lipids in VIS (r = [0.18; 0.34], p = [2.98  1021; 1.69 
1006]) could be replicated in both NSPHS and ORCADES
(Table 3). Association results for all glycan and all lipid
parameters in all cohorts are available in Table S4, ESI.w
Heatmaps displaying association results for all glycan and all lipid
parameters in all cohorts are presented in Fig. S1–S10, ESI.w
Fig. 1 Signiﬁcant correlations betweenN-glycans and lipids in the VIS cohort (Croatia) under fasting conditions. Glycan and lipids which did not
show any signiﬁcant associations were omitted. Cells with non-signiﬁcant correlations are displayed in grey. (A) Color key for the heatmap and a
histogram of the overall distribution of Pearson r values. (B) Heatmap coding the Pearson r value in color.
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Discussion
We conducted a comprehensive glycome-wide and lipidome-
wide association study in three local populations in Croatia,
Sweden, and Great Britain. We found strong associations
between N-glycans and classical lipids, glycerophospholipids,
and sphingolipids in each population and to a lesser degree
also across populations. Bi- and triantennary glycans showed
Fig. 2 Signiﬁcant correlations between N-glycans and lipids in the NSPHS cohort (Sweden) under non-fasting conditions. Glycan and lipids
which did not show any signiﬁcant associations were omitted. Cells with non-signiﬁcant correlations are displayed in grey. (A) Color key for the
heatmap and a histogram of the overall distribution of Pearson r values. (B) Heatmap coding the Pearson r value in color.
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a complementary pattern of glycan-lipid associations in Croatia,
and partially in Sweden. A similar complementary pattern of
mono- and disialylated glycans existed in Great Britain. The most
prominent association between lipids and glycans was the repeated
pattern of positive associations of polyunsaturated glycerolipids
with triantennary (including trigalactosylated and trisialylated)
Fig. 3 Signiﬁcant correlations between N-glycans and lipids in the ORCADES cohort (Great Britain) under fasting conditions. Glycan and lipids
which did not show any signiﬁcant associations were omitted. Cells with non-signiﬁcant correlations are displayed in grey. (A) Color key for the
heatmap and a histogram of the overall distribution of Pearson r values. (B) Heatmap coding the Pearson r value in color.
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glycans, and negative correlations of the same lipids with
biantennary (bigalactosylated and disialylated) glycans. For
two prominent groups of triantennary glycans, DG8 and DG10,
this association was replicated in all three populations. Although
little is known about associations between glycans and lipids, we
would like to discuss two potential interactive pathways between
glycans and lipids which could account for these observations.
The number of antennas on N-glycans is determined by the
activity of medial Golgi enzymes N-acetylglucosaminyl-
transferases II, III, IV, and V that determine branching
by the addition of N-acetlyglucosamine to core manoses.51
If increased desaturation of glycerolphospholipids in medial
Golgi is unfavorable for the activity of N-acetylglucosaminyl-
transferases II, IV and V, this could result in a decrease of
glycan branching and explain the observed associations.
Additionally, negative correlations between branched glycans
and unsaturated fatty acids could be a sort of a compensatory
mechanism. Changes in the degree of saturation of acyl chains
in both PC and PE were reported to aﬀect membrane domain
formation and modulate phase separation from lipid raft
molecules.52,53 Lipid rafts are believed to modulate signaling
events in a number of diﬀerent ways according to the composi-
tion of the speciﬁc subpopulations. Polyunsaturated fatty
acids and sterols possess a mutual aversion that drives the
lateral segregation of phospholipids into highly disordered
domains away from cholesterol. Triantennary glycans have
the exact opposite eﬀect on the formation of ordered lipid raft
structures in the membrane. While polyunsaturated fatty acids
increase disorder within the membrane bilayer, branched
glycans increase order by promoting clustering of glycosylated
membrane receptors by galectin-3.54 Therefore, a possible
explanation for the positive correlation between these two
opposing functions is that individuals which have increased
levels of polyunsaturated acids might compensate this by
increasing glycan branching, and vice versa.
Strengths and weaknesses
We conducted the ﬁrst large-scale, comprehensive glycome-wide
and lipidome-wide association study in three rural, population-
representative cohorts from Croatia, Sweden, and Great
Britain. We examined a broad spectrum of glycomics and
lipidomics traits which were quantiﬁed by state-of-the-art
Table 2 Number of signiﬁcant glycan and lipid associations in VIS
(Croatia, fasting) which were replicated in ORCADES (Great Britain,
fasting)
LIPIDS
GLYCANS
DG8 TRIA DG10 BAMS GP15 GP12 Sum
PE 6 5 11
PC 4 3 1 1 9
CER 7 7
LPC 1 2 3
SPM 1 1
Sum 11 8 8 2 1 1 31
Table 1 Number of signiﬁcant glycan and lipid associations in VIS (Croatia, fasting) which were replicated in NSPHS (Sweden, non-fasting)
LIPIDS
GLYCANS
DG10 GP12 GP13 G3 GP11 DG8 Trisialo GP8 BA Disialo TRIA Sum
PC 5 12 10 4 1 1 1 2 2 1 39
SPM 13 13
CER 6 3 9
TG 1 1 1 1 4
LPC 1 2 3
TC 1 1 2
LDL-C 1 1
Sum 27 13 10 5 4 3 2 2 2 2 1 71
Fig. 4 A schematic representation of the glycan and lipid molecules that were found to be signiﬁcantly associated in this study. R denotes
saturated fatty acid.
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laboratory methods which have become available only recently.
The glycan and lipid traits cover the most important species of
these omics in human cells. These traits were quantiﬁed in a
very large number of individuals in three diﬀerent local popula-
tions in Europe. The remote location of these populations
required substantially more ﬁnancial and logistic resources
than a comparable data collection in an urban population.
The pedigree-based population structure made the applica-
tion of sophisticated statistical models and high-performance
computing servers necessary to obtain the correct statistical
inference.
However, the scientiﬁc evidence from this study is also
reduced for a number of reasons. First, the data has been
collected using an epidemiological study design. Therefore, the
association of two traits does not allow any conclusions about
their casual relationship. Additionally, associations can be
caused by other confounders which cause a statistical associa-
tion without implying an interactive metabolic pathway.
However, at the current, very early state of research on these
omics traits, even these results can provide very important
information and can point out potentially important metabolic
pathways. Additionally, the speciﬁc patterns of associations
found in each of the populations do not make an explanation
by confounders very plausible.
Second, the populations show substantial diﬀerences regarding
environmental and genetic factors, since they live in very
diﬀerent locations regarding geography, climate, and lifestyle.
Therefore, the patterns of association between glycans and
lipids can be truly diﬀerent in each population, making it
very diﬃcult to replicate associations in another population.
However, on the other side the associations found across
all populations are probably extremely robust. Additionally,
the diﬀerences between the populations will allow the study of
environmental and genetic eﬀects on omics traits in follow-up
studies.
Third, we only measured glycan and lipid levels in the
human blood, therefore, we cannot make reliable conclusions
about the concentration or availability of the examined species
in other tissues or body compartments. However, it is plausible
to assume that the blood as the central transport medium will
reﬂect bioavailability of these substances in the body.
Fourth, glycans were measured as relative levels compared
to the overall glycome, lipids were measured as absolute levels.
This should be kept in mind when interpreting the results as it
can lead to methodological artifacts since an increase in the
concentration of one glycan will aﬀect the relative level of the
glycan itself but also of all other glycans in the glycome.
Therefore, it is unclear whether the reported complementary
pattern of glycan-lipid associations has been caused by an
increase of one glycan, a decrease of another one, or both, for
example, if one glycan is metabolized to another glycan.
Fifth, we adjusted the glycan and lipid levels for sex and age.
Therefore, associations between glycans and lipids which were
caused by sex or age diﬀerences have been ﬁltered out. One
might argue to drop even those covariates to obtain the
complete pattern of glycan-lipid associations. However, we
chose this model to ﬁnd generic potential metabolic pathways
independent of sex and age eﬀects.
Conclusions
Our study demonstrates that high-throughput studies of
glycomics and lipidomics traits in large-scale population-based
studies are feasible now. The results point towards generic
interactive metabolic pathways between glycans and lipids
across all populations, but also show speciﬁc associations for
each population which can be caused by environmental and
genetic diﬀerences.
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